Hooper Suzanne Sawochka 4
4 · Eidos Therapeutics, Inc. · Filed Aug 10, 2020
Insider Transaction Report
Form 4
Hooper Suzanne Sawochka
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-08-06+21,447→ 21,447 totalExercise: $41.42Exp: 2030-08-05→ Common Stock (21,447 underlying) - Award
Restricted Stock Units
2020-08-06+4,526→ 4,526 total→ Common Stock (4,526 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The shares of Common Stock underlying the RSUs vest in three annual installments after the date of grant, subject to the Reporting Person's continued service on the Issuer's board of directors as of each vesting date.
- [F3]The stock option shall vest in three annual installments after the date of grant, subject to the Reporting Person's continued service on the Issuer's board of directors as of each vesting date.